Acasti Pharma (NASDAQ:ACST – Get Rating) is set to release its earnings data before the market opens on Tuesday, June 21st. Analysts expect Acasti Pharma to post earnings of ($0.13) per share for the quarter. NASDAQ:ACST traded up $0.02 on Friday, reaching $0.92. The stock had a trading volume of 1,200 shares, compared to its […]
Analysts expect Acasti Pharma Inc. (NASDAQ:ACST – Get Rating) to announce earnings of ($0.13) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Acasti Pharma’s earnings. Acasti Pharma reported earnings per share of ($0.24) in the same quarter last year, which suggests a positive year-over-year growth rate of […]
/PRNewswire/ Acasti Pharma Inc. (Nasdaq: ACST and TSX-V: ACST) ("Acasti"; the "Company"), a late-stage specialty pharmaceutical company with drug delivery.
/PRNewswire/ Acasti Pharma Inc. (Nasdaq: ACST and TSX-V: ACST) ("Acasti"; the "Company"), a late-stage specialty pharmaceutical company with drug delivery.